At what age can a patient undergo a Middle Cerebral Artery (MCA) doppler test?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 21, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

MCA Doppler Age Guidelines

For fetal assessment, MCA Doppler should be performed starting at 18-20 weeks of gestation when technically feasible, with routine surveillance beginning at 32 weeks for fetal growth restriction and at 2 years of age for sickle cell disease screening in children. 1

Fetal MCA Doppler Timing

For Fetal Anemia Screening

  • MCA peak systolic velocity (MCA-PSV) measurements can begin at 18 weeks of gestation, which is when fetal blood sampling or intrauterine transfusion becomes technically feasible 1
  • Surveillance should be reserved until the pregnancy is advanced enough (typically 18-20 weeks) for intervention to be possible 1
  • After 24 weeks of gestation, routine testing is performed weekly, but may be done more frequently with higher MoM levels or other abnormal findings 1

For Fetal Growth Restriction (FGR)

  • MCA Doppler assessment is primarily indicated after 32 weeks of gestation for late-onset FGR, as this is when cerebral blood flow redistribution becomes most clinically relevant 2, 1
  • Before 32 weeks, umbilical artery Doppler is the primary monitoring tool for early-onset FGR 2
  • Multiple guidelines recommend MCA Doppler at >32 weeks or after 34 weeks when FGR is diagnosed 1, 2

Surveillance Frequency in FGR

  • For FGR with estimated fetal weight ≥3rd-9th percentile: MCA Doppler every 2 weeks after 32 weeks 2
  • For severe FGR with estimated fetal weight <3rd percentile: weekly umbilical artery Doppler, with MCA Doppler added after 32 weeks 2
  • New Zealand guidelines specifically recommend MCA Doppler and cerebroplacental ratio every 2 weeks after 34 weeks 2

Pediatric MCA Doppler Timing

For Sickle Cell Disease Screening

  • The National Heart Lung and Blood Institute recommends transcranial Doppler ultrasound screening for children with sickle cell disease between 2 and 16 years of age, performed every 6 months 1
  • Velocity measurements from the distal internal carotid artery or proximal middle cerebral artery assess stroke risk 1
  • Time-averaged means of maximum velocity <170 cm/sec indicate low stroke risk, 170-199 cm/sec indicate intermediate risk, and >200 cm/sec indicate high risk (40% in next 3 years) 1

For Acute Stroke Evaluation

  • MRA of the head (which includes MCA assessment) is appropriate for initial imaging in children >6 months of age with acute stroke presentation 1
  • MRA is the study of choice to screen for vessel stenosis in children with sickle cell disease who have elevated transcranial Doppler velocities 1

Common Pitfalls to Avoid

  • Do not perform MCA Doppler before 32 weeks for routine FGR surveillance, as umbilical artery Doppler is the primary tool in early-onset FGR and MCA findings are less clinically relevant before this gestational age 2
  • Do not delay transcranial Doppler screening in children with sickle cell disease beyond 2 years of age, as early detection of elevated velocities allows for preventive transfusion therapy to reduce stroke risk 1
  • Do not rely on MCA Doppler alone for fetal anemia assessment—the proper technique requires specific measurements at the origin of the MCA from the internal carotid artery, with at least 3 measurements taken and the highest value used 1
  • Avoid performing fetal MCA-PSV measurements during fetal movement or breathing, as changes in fetal heart rate can impact the MCA-PSV values 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Middle Cerebral Artery Doppler Assessment in Fetal Growth Restriction

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.